Thye Dirk (CIK 1638945) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-12). Recent activity: Sell QNCX (739,885 shares), Buy QNCX (739,885 shares), Buy QNCX (150,944 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | Quince Therapeutics, Inc. (QNCX) | CEO and CMO | Sell | 739,885 | $0 |
| 2025-12-12 | Quince Therapeutics, Inc. (QNCX) | CEO and CMO | Buy | 739,885 | $0 |
| 2025-06-23 | Quince Therapeutics, Inc. (QNCX) | CEO and CMO | Buy | 150,944 | $181,133 |
Source: SEC Form 4 filings · as of 2025-12-12